Advertisement
Intravenous cyclosporine does not improve outcomes versus placebo in patients with anterior ST-segment elevation myocardial infarction who had been referred for primary percutaneous coronary intervention. The findings were published online Aug. 30 in the New England Journal of Medicine to coincide with the annual European Society of Cardiology Congress

Intravenous Cyclosporine Doesn’t Improve STEMI Outcomes

0
For patients undergoing PCI, cyclosporine doesn't prevent adverse left ventricular remodeling at 1 year
Use of dipeptidyl peptidase-4 inhibitors in type 2 diabetes is tied to severe joint pain in some patients

FDA Warns of Joint Pain Tied to DPP-4 Inhibitors

0
Agency advises users with such symptoms to contact their doctor
Taking antibiotics might increase the risk of developing type 2 diabetes

Antibiotic Use Linked to Higher Type 2 Diabetes Risk

0
Researchers don't know if the drugs signal developing disease, or contribute to it
Older women with osteoporosis may benefit from a few years on growth hormone

Growth Hormone May Benefit Bone Health in Older Women

0
But researcher says high cost, need to get shots in clinics make it an unlikely osteoporosis treatment
Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration

FDA Approves Repatha for Certain Patients With High Cholesterol

0
Approved for patients unable to get LDL cholesterol under control with current treatment options
Many elderly oncology patients use complementary and alternative medications

Many Elderly Oncology Patients Taking Alternative Medicines

0
Associated with polypharmacy, vision impairment, and urologic comorbidities
Azithromycin is routinely prescribed to hospitalized patients despite risk factors for corrected QT prolongation and administration of interacting medications

Azithromycin Routine in Hospital Despite Risk for QTc Prolongation

0
Providers not considering risk of QTc-prolonging meds accumulation, authors say
The outcome of a recent case regarding the termination of physicians by an insurance company following a dispute over the necessity of medical services provided has serious implications for physicians and their patients

AMA: Ruling Makes It Easier for Insurers to Terminate Doctors

0
Court supported insurance company in termination of doctors after dispute over necessity of services
For patients taking dabigatran

Lower Risk of Dabigatran-Tied Bleeding With Gastroprotection

0
Concomitant use of gastroprotective agents linked to lower risk of gastrointestinal bleeding
Patients with psoriasis are at higher risk of developing arrhythmia

Psoriasis Patients at Higher Risk for Arrhythmia

0
Findings in patients with mild, severe disease and with/without psoriatic arthritis